Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cardiovascular Device

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2003239

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2003239

Cardiac Monitoring & Rhythm Management Devices Market by Type (Cardiac Monitoring, Cardiac Rhythm Management (Pacemaker ), Defibrillator ), Application, End User - Global Forecast to 2031

PUBLISHED:
PAGES: 491 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global cardiac monitoring and cardiac rhythm management devices market is projected to reach USD 37.88 billion by 2031, up from USD 27.90 billion in 2026, growing at a CAGR of 6.3% over the forecast period.

Scope of the Report
Years Considered for the Study2024-2031
Base Year2025
Forecast Period2025-2031
Units ConsideredValue (USD billion)
SegmentsType, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Market growth is driven by factors such as rising public awareness campaigns and screening programs aimed at early detection of cardiovascular diseases, which contribute to growing demand for cardiac monitoring devices, especially in high-risk populations. On the other hand, the adoption of remote monitoring and telemedicine technologies raises concerns about data security and patient privacy, which may hinder patient acceptance and adoption of these devices.

Cardiac Monitoring & Rhythm Management Devices Market - IMG1

"The implantable cardioverter defibrillators accounted for the largest market share in the cardiac rhythm management device market, during the forecast period."

By type, cardiac rhythm management devices in the market are classified into implantable cardioverter defibrillators and external defibrillators. In 2025, implantable cardioverter defibrillators accounted for a sizable market share because they provide continuous protection against sudden cardiac arrest by continuously monitor the heart's rhythm and deliver appropriate therapy when needed, protecting against sudden cardiac arrest. This constant monitoring and intervention offer round-the-clock protection for patients at risk of life-threatening arrhythmias, whereas external defibrillators are typically used for acute interventions in emergencies. Likewise, Implantable defibrillators are implanted surgically or via minimally invasive procedures in patients at high risk of sudden cardiac death due to underlying cardiac conditions such as ventricular arrhythmias or cardiomyopathy. They are intended for long-term use and are suitable for patients who require ongoing arrhythmia management. In contrast, external defibrillators, such as automated external defibrillators (AEDs) or manual defibrillators used in hospitals, are used mainly for emergency resuscitation in cases of cardiac arrest.

The home care settings are projected to register the highest CAGR during the forecast period."

In the cardiac monitoring and rhythm management devices market, the home care segment is the fastest-growing end user due to the growing shift toward remote patient monitoring and home-based cardiac care. Advances in wearable, portable, and connected devices enable continuous monitoring and rhythm management outside traditional clinical settings, improving patient convenience and outcomes. Additionally, rising prevalence of chronic cardiac conditions, an aging population, and efforts to reduce hospitalizations and healthcare costs are further accelerating the adoption of these devices in home care environments.

"The North American region accounted for the highest share."

The global cardiac monitoring and cardiac rhythm management devices market is divided into four regions: North America, Asia-Pacific, Europe, and the Rest of the World. According to the regional analysis, the North American region is likely to retain a significant market share in 2025 and beyond. The North American market is being propelled by rising cases of heart disease, increased healthcare expenditure, and greater awareness of early disease diagnosis.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 32%, Tier 2 - 44%, and Tier 3 - 24%
  • By Designation: C-level - 30%, D-level - 34%, and Others - 36%
  • By Region: North America - 40%, Europe - 28%, Asia Pacific - 20%, and the Rest of the World - 12%

The prominent players in the GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Boston Scientific Corporation (US), Baxter (US), Medtronic (Ireland), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (US), Stryker (US), NIHON KOHDEN CORPORATION (Japan), MicroPort Scientific Corporation (China), FUKUDA DENSHI (Japan), OSI Systems, Inc. (US), iRhythm Inc. (US), Lepu Medical Technology (Beijing) Co., Ltd. (China), and AliveCor, Inc. (US) among others.

Research Coverage

This report studies the Cardiac monitoring and cardiac rhythm management devices market based on type, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets by their individual growth trends and forecasts market segment revenue for five central regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the market pulse, which, in turn, will help them garner a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.

This report provides insights into the following pointers:

  • Analysis of key drivers (rapidly expanding global geriatric population and subsequent surge in cardiac diseases, increasing incidence of lifestyle and cardiovascular diseases), restraints (rapidly expanding global geriatric population and subsequent surge in cardiac diseases, Increasing incidence of lifestyle and cardiovascular diseases), opportunities (untapped growth potential in emerging markets), and challenges (frequent product recalls) influencing the growth of the cardiac monitoring and cardiac rhythm management devices market
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the Cardiac monitoring and cardiac rhythm management devices market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product developments in the Cardiac monitoring and cardiac rhythm management devices market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the Cardiac monitoring and cardiac rhythm management devices market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
Show more
Product Code: MD 1038

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 TUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 CARDIAC MONITORING AND RHYTHM MANAGEMENT MARKET DEVICES MARKET OVERVIEW
  • 3.2 ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION AND COUNTRY
  • 3.3 GEOGRAPHIC SNAPSHOT OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising geriatric population with chronic cardiovascular diseases
      • 4.2.1.2 Increasing incidence of lifestyle and cardiovascular diseases
      • 4.2.1.3 Development of wireless monitoring and wearable cardiac devices
      • 4.2.1.4 Rapid adoption of leadless pacemakers
      • 4.2.1.5 Increasing focus on providing public-access defibrillators
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Increasing regulatory scrutiny extending time-to-market for cardiac devices
      • 4.2.2.2 High device costs and reimbursement gaps
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Untapped growth potential in emerging markets
      • 4.2.3.2 Emergence of leadless CRT platforms
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Frequent product recalls
  • 4.3 UNMET NEEDS & WHITE SPACES
    • 4.3.1 UNMET NEEDS
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 KEY STRATEGIC MOVES BY TIER-1/2/3 PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 BARGAINING POWER OF SUPPLIERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMICS OUTLOOK
    • 5.2.1 GDP TRENDS AND FORECAST
    • 5.2.2 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
    • 5.2.3 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
  • 5.3 SUPPLY CHAIN ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
    • 5.5.1 ROLE IN ECOSYSTEM
  • 5.6 PRICING ANALYSIS
    • 5.6.1 AVERAGE SELLING PRICE TREND OF CARDIAC MONITORING DEVICES, BY KEY PLAYER, 2024 AND 2025 (USD)
      • 5.6.1.1 Average selling price of Holter monitors, by key player, 2025
      • 5.6.1.2 Average selling price of external defibrillators, by key player, 2024
    • 5.6.2 AVERAGE SELLING PRICE TREND OF CARDIAC RHYTHM MANAGEMENT DEVICES, BY REGION, 2023-2025
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT DATA FOR HS CODE 901811, 2021-2024
    • 5.7.2 EXPORT DATA FOR HS CODE 901811, 2021-2024
  • 5.8 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.10 INVESTMENT & FUNDING SCENARIO
  • 5.11 CASE STUDY ANALYSIS
    • 5.11.1 DUAL-CHAMBER LEADLESS PACEMAKER BY ABBOTT
    • 5.11.2 CARDIOSOFT ECG-BICESTER HEALTH CENTRE IN NUMED HEALTHCARE
    • 5.11.3 POST-STROKE ATRIAL FIBRILLATION DETECTION WITH PHILIPS BIOTEL HEART MCOT
  • 5.12 IMPACT OF 2025 US TARIFF ON CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET
    • 5.12.1 KEY TARIFF RATES
    • 5.12.2 PRICE IMPACT ANALYSIS
    • 5.12.3 IMPACT ON COUNTRY/REGION
    • 5.12.4 IMPACT ON END-USE INDUSTRIES

6 DSTRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS

  • 6.1 TECHNOLOGY ANALYSIS
    • 6.1.1 KEY EMERGING TECHNOLOGIES
      • 6.1.1.1 Artificial intelligence (AI) and predictive analytics
      • 6.1.1.2 Miniaturization of cardiac devices
    • 6.1.2 COMPLEMENTARY TECHNOLOGIES
      • 6.1.2.1 Wearable biosensors
    • 6.1.3 ADJACENT TECHNOLOGIES
      • 6.1.3.1 Vital sign monitors
  • 6.2 TECHNOLOGY/PRODUCT ROADMAP
    • 6.2.1 NEAR TERM (2025-2027)
    • 6.2.2 MID TERM (2028-2030)
    • 6.2.3 LONG TERM (2030+)
  • 6.3 PATENT ANALYSIS
    • 6.3.1 JURISDICTION AND TOP APPLICANT ANALYSIS
  • 6.4 FUTURE APPLICATIONS
    • 6.4.1 FULLY AUTONOMOUS CARDIAC DIAGNOSTICS & DECISION-SUPPORT ECOSYSTEMS
    • 6.4.2 PRECISION RHYTHM MANAGEMENT THROUGH PREDICTIVE & PRE-EMPTIVE THERAPY DELIVERY
    • 6.4.3 FULLY LEADLESS, MODULAR, AND WIRELESSLY NETWORKED CARDIAC SYSTEMS
    • 6.4.4 REGENERATIVE-INTEGRATED RHYTHM MANAGEMENT SYSTEMS
  • 6.5 IMPACT OF AI/GEN AI ON CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET
    • 6.5.1 MARKET POTENTIAL OF AI
    • 6.5.2 AI USE CASES
    • 6.5.3 KEY COMPANIES IMPLEMENTING AI
    • 6.5.4 BEST PRACTICES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES
    • 6.5.5 CASE STUDIES OF AI IMPLEMENTATION
    • 6.5.6 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.5.7 CLIENTS' READINESS TO ADOPT GENERATIVE AI

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

  • 7.1 REGULATORY LANDSCAPE
    • 7.1.1 REGULATORY FRAMEWORK
      • 7.1.1.1 North America
      • 7.1.1.2 Europe
      • 7.1.1.3 Asia Pacific
      • 7.1.1.4 Latin America
      • 7.1.1.5 Middle East & Africa
    • 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.3 INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 RECYCLABLE BIOMATERIALS FOR ECG PATCHES
    • 7.2.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
    • 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 KEY STAKEHOLDERS & BUYING CRITERIA
    • 8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.1.2 BUYING CRITERIA
  • 8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
    • 8.2.1 DECISION-MAKING PROCESS
    • 8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES
    • 8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
    • 8.2.4 MARKET PROFITABILITY

9 RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 PACEMAKERS
    • 9.2.1 SINGLE-CHAMBER PACEMAKERS
      • 9.2.1.1 Increasing use of single-chamber pacemakers for managing bradyarrhythmias and conduction disorders to aid market growth
    • 9.2.2 DUAL-CHAMBER PACEMAKERS
      • 9.2.2.1 Dual-chamber pacemakers to witness high demand with widespread usage
    • 9.2.3 LEADLESS CHAMBER PACEMAKERS
      • 9.2.3.1 Focus on minimally invasive implantation and reduced complication rates to propel market growth
  • 9.3 DEFIBRILLATORS
    • 9.3.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)
      • 9.3.1.1 Single-chamber implantable cardioverter-defibrillators (ICDs)
        • 9.3.1.1.1 Utilization in arterial monitoring to support market growth
      • 9.3.1.2 Dual-chamber implantable cardioverter-defibrillators (ICDs)
        • 9.3.1.2.1 Ability to reduce incidence of inappropriate shocks to drive market
      • 9.3.1.3 Subcutaneous implantable cardioverter-defibrillators (ICDs)
        • 9.3.1.3.1 Benefits of eliminating cardiac leads to drive market
    • 9.3.2 EXTERNAL DEFIBRILLATORS
      • 9.3.2.1 Automated external defibrillators (AEDs)
        • 9.3.2.1.1 Smart automated external defibrillators advancing public cardiac emergency response to aid market growth
      • 9.3.2.2 Manual external defibrillators
        • 9.3.2.2.1 Innovation in manual external defibrillators to enhance emergency cardiac care
      • 9.3.2.3 Wearable cardioverter defibrillators (WCDs)
        • 9.3.2.3.1 Operational difficulties and false alarms to restrain market adoption
  • 9.4 CARDIAC RESYNCHRONIZATION THERAPY (CRT)
    • 9.4.1 CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS (CRT-P)
    • 9.4.2 CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATORS (CRT-D)

10 CARDIAC MONITORING DEVICES MARKET, BY TYPE

  • 10.1 INTRODUCTION
  • 10.2 NON-INVASIVE CARDIAC MONITORING DEVICES
    • 10.2.1 ELECTROCARDIOGRAM (ECG/EKG) MONITORS
      • 10.2.1.1 Standard 12-lead ECG machines (resting ECG monitors)
        • 10.2.1.1.1 Wide availability of resting ECG devices to support market growth
      • 10.2.1.2 Stress ECG systems
        • 10.2.1.2.1 High cost of stress ECG devices to limit adoption
      • 10.2.1.3 Handheld/Smart ECG monitors
        • 10.2.1.3.1 Rising adoption of AI technology and growing need to minimize treatment costs to support market growth
    • 10.2.2 AMBULATORY CARDIAC MONITORS
      • 10.2.2.1 Holter monitors
        • 10.2.2.1.1 Growing demand for continuous monitoring to fuel segment growth
      • 10.2.2.2 Event monitors
        • 10.2.2.2.1 Increasing outsourcing of monitoring devices to propel market growth
      • 10.2.2.3 Mobile cardiac telemetry (MCT) devices
        • 10.2.2.3.1 Increasing demand for cardiac monitoring solutions in home care settings to aid segment growth
      • 10.2.2.4 Long-term continuous ECG monitors
        • 10.2.2.4.1 Increasing adoption of patch-based ECG monitors for extended ambulatory cardiac monitoring to aid market growth
  • 10.3 INVASIVE CARDIAC MONITORING DEVICES
    • 10.3.1 INTRODUCTION OF TECHNOLOGICALLY ADVANCED IMPLANTABLE LOOP RECORDERS TO SUPPORT MARKET GROWTH

11 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION

  • 11.1 INTRODUCTION
  • 11.2 ARRHYTHMIAS
    • 11.2.1 GROWING NUMBER OF ATRIAL FIBRILLATION CASES TO DRIVE MARKET
  • 11.3 HEART FAILURE
    • 11.3.1 GROWING PREVALENCE OF CHRONIC LIFESTYLE DISEASES TO DRIVE PREVALENCE OF HEART FAILURE
  • 11.4 MYOCARDIAL INFARCTION (MI)
    • 11.4.1 RISING GERIATRIC POPULATION TO SPUR MARKET GROWTH
  • 11.5 OTHER APPLICATIONS

12 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER

  • 12.1 INTRODUCTION
  • 12.2 HOSPITALS
    • 12.2.1 INCREASING UTILIZATION OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES IN HOSPITALS TO AID MARKET GROWTH
  • 12.3 PRIMARY CARE CENTERS
    • 12.3.1 WIDENING ACCESS TO ECG MONITORING IN PRIMARY CARE CENTERS TO BOOST MARKET PENETRATION
  • 12.4 CARDIAC CENTERS
    • 12.4.1 INCREASED INCIDENCE OF CARDIOVASCULAR DISEASE AND HIGH DEMAND FOR SPECIALIZED CARE TO BOOST MARKET GROWTH
  • 12.5 AMBULATORY SURGICAL CENTERS
    • 12.5.1 GROWING NEED FOR PRE-OPERATIVE CARDIAC SCREENING IN AMBULATORY SURGICAL CENTERS TO INFLUENCE MARKET DEMAND
  • 12.6 HOME CARE SETTINGS
    • 12.6.1 RISING PREFERENCE FOR REMOTE CARDIAC MONITORING TO FUEL MARKET GROWTH
  • 12.7 OTHER END USERS

13 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY REGION

  • 13.1 INTRODUCTION
  • 13.2 NORTH AMERICA
    • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 13.2.2 US
      • 13.2.2.1 US to dominate North American cardiac monitoring and rhythm management devices market during forecast period
    • 13.2.3 CANADA
      • 13.2.3.1 High burden of cardiovascular diseases to support market growth
  • 13.3 EUROPE
    • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 13.3.2 GERMANY
      • 13.3.2.1 High healthcare spending to propel market growth
    • 13.3.3 FRANCE
      • 13.3.3.1 Favorable government initiatives to support market growth
    • 13.3.4 UK
      • 13.3.4.1 Rising demand for home-based smart ECG devices to support market growth
    • 13.3.5 ITALY
      • 13.3.5.1 Growing focus on improvements in patient care to drive market
    • 13.3.6 SPAIN
      • 13.3.6.1 Rising geriatric population to support market growth in Spain
    • 13.3.7 AUSTRIA
      • 13.3.7.1 Favourable insurance coverage for cardiac diagnostic procedures to support market growth
    • 13.3.8 NETHERLANDS
      • 13.3.8.1 Strong primary care referral pathway to aid adoption of cardiac monitoring and rhythm devices
    • 13.3.9 SWEDEN
      • 13.3.9.1 Expansion of long-term ambulatory ECG monitoring to augment market growth
    • 13.3.10 REST OF EUROPE
  • 13.4 ASIA PACIFIC
    • 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 13.4.2 JAPAN
      • 13.4.2.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth
    • 13.4.3 CHINA
      • 13.4.3.1 Government support for infrastructural improvement to drive market
    • 13.4.4 INDIA
      • 13.4.4.1 Increasing cardiac disease burden intensifies demand for cardiac monitoring and rhythm management devices
    • 13.4.5 AUSTRALIA
      • 13.4.5.1 Australia to strengthen community access to rhythm management devices through policy and targeted funding
    • 13.4.6 SOUTH KOREA
      • 13.4.6.1 Rising geriatric population to propel market growth
    • 13.4.7 REST OF ASIA PACIFIC
  • 13.5 LATIN AMERICA
    • 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 13.5.2 BRAZIL
      • 13.5.2.1 Improving access to diagnostic services to drive market growth
    • 13.5.3 MEXICO
      • 13.5.3.1 Rising incidences of heart disease to propel market growth
    • 13.5.4 COLOMBIA
      • 13.5.4.1 High arrhythmia burden to drive demand for cardiac rhythm monitoring in Colombia
    • 13.5.5 REST OF LATIN AMERICA
  • 13.6 MIDDLE EAST & AFRICA
    • 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 13.6.2 GCC COUNTRIES
      • 13.6.2.1 Kingdom of Saudi Arabia
        • 13.6.2.1.1 High prevalence of cardiovascular diseases and increased demand for cardiac diagnostic solutions to drive market
      • 13.6.2.2 UAE
        • 13.6.2.2.1 Focus on national CVD screening programs and digital health strategies to augment market growth
      • 13.6.2.3 Rest of GCC Countries
    • 13.6.3 REST OF MIDDLE EAST & AFRICA

14 COMPETITIVE LANDSCAPE

  • 14.1 INTRODUCTION
  • 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • 14.3 REVENUE ANALYSIS, 2022-2024
  • 14.4 MARKET SHARE ANALYSIS, 2025
  • 14.5 BRAND COMPARISON
  • 14.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 14.6.1 STARS
    • 14.6.2 EMERGING LEADERS
    • 14.6.3 PERVASIVE PLAYERS
    • 14.6.4 PARTICIPANTS
    • 14.6.5 COMPANY PRODUCT FOOTPRINT: KEY PLAYERS, 2024
      • 14.6.5.1 Company footprint
      • 14.6.5.2 Region footprint
      • 14.6.5.3 Type footprint
      • 14.6.5.4 Type footprint
      • 14.6.5.5 Application footprint
  • 14.7 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2024
    • 14.7.1 PROGRESSIVE COMPANIES
    • 14.7.2 RESPONSIVE COMPANIES
    • 14.7.3 DYNAMIC COMPANIES
    • 14.7.4 STARTING BLOCKS
    • 14.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 14.7.5.1 Detailed list of key startups/SMEs
      • 14.7.5.2 Competitive benchmarking of key startups/SMEs
  • 14.8 COMPANY VALUATION & FINANCIAL METRICS
    • 14.8.1 FINANCIAL METRICS
    • 14.8.2 COMPANY VALUATION
  • 14.9 COMPETITIVE SCENARIO
    • 14.9.1 PRODUCT LAUNCHES & APPROVALS
    • 14.9.2 DEALS
    • 14.9.3 EXPANSIONS
    • 14.9.4 OTHER DEVELOPMENTS

15 COMPANY PROFILES

  • 15.1 KEY PLAYERS
    • 15.1.1 GE HEALTHCARE
      • 15.1.1.1 Business overview
      • 15.1.1.2 Products offered
      • 15.1.1.3 Recent developments
        • 15.1.1.3.1 Deals
        • 15.1.1.3.2 Other developments
      • 15.1.1.4 MnM view
        • 15.1.1.4.1 Right to win
        • 15.1.1.4.2 Strategic choices
        • 15.1.1.4.3 Weaknesses & competitive threats
    • 15.1.2 KONINKLIJKE PHILIPS N.V.
      • 15.1.2.1 Business overview
      • 15.1.2.2 Products offered
      • 15.1.2.3 Recent developments
        • 15.1.2.3.1 Product launches
        • 15.1.2.3.2 Deals
        • 15.1.2.3.3 Expansions
        • 15.1.2.3.4 Other developments
      • 15.1.2.4 MnM view
        • 15.1.2.4.1 Right to win
        • 15.1.2.4.2 Strategic choices
        • 15.1.2.4.3 Weaknesses & competitive threats
    • 15.1.3 BOSTON SCIENTIFIC CORPORATION
      • 15.1.3.1 Business overview
      • 15.1.3.2 Products offered
      • 15.1.3.3 Recent developments
        • 15.1.3.3.1 Product approvals
        • 15.1.3.3.2 Deals
      • 15.1.3.4 MnM view
        • 15.1.3.4.1 Right to win
        • 15.1.3.4.2 Strategic choices
        • 15.1.3.4.3 Weaknesses & competitive threats
    • 15.1.4 BAXTER (HILL-ROM HOLDINGS, INC.)
      • 15.1.4.1 Business overview
      • 15.1.4.2 Products offered
    • 15.1.5 MEDTRONIC
      • 15.1.5.1 Business overview
      • 15.1.5.2 Products offered
      • 15.1.5.3 Recent developments
        • 15.1.5.3.1 Product approvals
      • 15.1.5.4 MnM view
        • 15.1.5.4.1 Right to win
        • 15.1.5.4.2 Strategic choices
        • 15.1.5.4.3 Weaknesses & competitive threats
    • 15.1.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
      • 15.1.6.1 Business overview
      • 15.1.6.2 Products offered
      • 15.1.6.3 Recent developments
        • 15.1.6.3.1 Product launches & approvals
        • 15.1.6.3.2 Other developments
    • 15.1.7 ABBOTT
      • 15.1.7.1 Business overview
      • 15.1.7.2 Products offered
      • 15.1.7.3 Recent developments
        • 15.1.7.3.1 Product launches & approvals
    • 15.1.8 STRYKER
      • 15.1.8.1 Business overview
      • 15.1.8.2 Products offered
      • 15.1.8.3 Recent developments
        • 15.1.8.3.1 Product launches
        • 15.1.8.3.2 Deals
        • 15.1.8.3.3 Other developments
    • 15.1.9 NIHON KOHDEN CORPORATION
      • 15.1.9.1 Business overview
      • 15.1.9.2 Products offered
    • 15.1.10 MICROPORT SCIENTIFIC CORPORATION
      • 15.1.10.1 Business overview
      • 15.1.10.2 Products offered
      • 15.1.10.3 Recent developments
        • 15.1.10.3.1 Product launches and approvals
    • 15.1.11 FUKUDA DENSHI
      • 15.1.11.1 Business overview
      • 15.1.11.2 Products offered
    • 15.1.12 OSI SYSTEMS, INC.
      • 15.1.12.1 Business overview
      • 15.1.12.2 Products offered
      • 15.1.12.3 Recent developments
        • 15.1.12.3.1 Expansions
    • 15.1.13 IRHYTHM INC.
      • 15.1.13.1 Business overview
      • 15.1.13.2 Products offered
      • 15.1.13.3 Recent developments
        • 15.1.13.3.1 Product launches and approvals
        • 15.1.13.3.2 Deals
    • 15.1.14 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
      • 15.1.14.1 Business overview
      • 15.1.14.2 Products offered
      • 15.1.14.3 Recent developments
        • 15.1.14.3.1 Product launches
    • 15.1.15 ALIVECOR, INC.
      • 15.1.15.1 Business overview
      • 15.1.15.2 Products offered
      • 15.1.15.3 Recent developments
        • 15.1.15.3.1 Product launches and approvals
        • 15.1.15.3.2 Deals
  • 15.2 OTHER PLAYERS
    • 15.2.1 SCHILLER
    • 15.2.2 CARDIAC INSIGHT, INC.
    • 15.2.3 BIOTRONIK
    • 15.2.4 BITTIUM
    • 15.2.5 BPL MEDICAL TECHNOLOGIES
    • 15.2.6 LIFESIGNALS
    • 15.2.7 CUMEDICAL
    • 15.2.8 BIOTRICITY
    • 15.2.9 EDAN INSTRUMENTS, INC.
    • 15.2.10 VITALCONNECT

16 RESEARCH METHODOLOGY

  • 16.1 RESEARCH DATA
    • 16.1.1 SECONDARY DATA
      • 16.1.1.1 Key secondary sources
      • 16.1.1.2 Key data from secondary sources
    • 16.1.2 PRIMARY DATA
      • 16.1.2.1 Primary sources
      • 16.1.2.2 Key objectives of primary research
      • 16.1.2.3 Key industry insights
      • 16.1.2.4 Breakdown of primaries
  • 16.2 MARKET SIZE ESTIMATION OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES
    • 16.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)
    • 16.2.2 MNM REPOSITORY ANALYSIS
    • 16.2.3 COMPANY INVESTORS PRESENTATIONS AND PRIMARY INTERVIEWS
    • 16.2.4 TOP-DOWN APPROACH
    • 16.2.5 BOTTOM-UP APPROACH
    • 16.2.6 PRIMARY INTERVIEWS
    • 16.2.7 DEMAND-SIDE APPROACH
  • 16.3 MARKET GROWTH RATE PROJECTION
  • 16.4 DATA TRIANGULATION
    • 16.4.1 STUDY ASSUMPTIONS
    • 16.4.2 RESEARCH LIMITATIONS
  • 16.5 RISK ANALYSIS

17 APPENDIX

  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.3 CUSTOMIZATION OPTIONS
    • 17.3.1 COMPANY INFORMATION
    • 17.3.2 GEOGRAPHIC ANALYSIS
    • 17.3.3 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
    • 17.3.4 COUNTRY-LEVEL VOLUME ANALYSIS
    • 17.3.5 ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUEST
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS
Show more
Product Code: MD 1038

List of Tables

  • TABLE 1 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 3 PRODUCT RECALLS BY US FDA, 2022-2025
  • TABLE 4 IMPACT OF PORTER'S FIVE FORCES ON CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET
  • TABLE 5 GDP CHANGE, BY COUNTRY, 2021-2030 (USD BILLION)
  • TABLE 6 ROLE OF KEY COMPANIES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET ECOSYSTEM
  • TABLE 7 AVERAGE SELLING PRICE TREND OF HOLTER MONITORS, BY REGION, 2023-2025 (USD)
  • TABLE 8 AVERAGE SELLING PRICE TREND 0F EXTERNAL DEFIBRILLATORS, BY REGION, 2023-2025 ((USD)
  • TABLE 9 IMPORT DATA FOR HS CODE 901811, BY COUNTRY, 2021-2024 (USD THOUSAND)
  • TABLE 10 EXPORT DATA FOR HS CODE 901811, BY COUNTRY, 2021-2024 (USD THOUSAND)
  • TABLE 11 MAJOR CONFERENCES & EVENTS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, JANUARY 2025-DECEMBER 2026
  • TABLE 12 CASE STUDY 1: DUAL-CHAMBER LEADLESS PACEMAKER BY ABBOTT
  • TABLE 13 CASE STUDY 2: CARDIOSOFT ECG-BICESTER HEALTH CENTRE IN NUMED HEALTHCARE
  • TABLE 14 CASE STUDY 3: POST-STROKE ATRIAL FIBRILLATION DETECTION WITH PHILIPS BIOTEL HEART MCOT
  • TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES, 2024
  • TABLE 16 KEY PRODUCT-RELATED TARIFF EFFECTIVE
  • TABLE 17 IMPACT OF US TARIFF ON CANADA
  • TABLE 18 IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA
  • TABLE 19 IMPACT OF US TARIFF ON GERMANY AND UK
  • TABLE 20 IMPACT OF US TARIFF ON MEXICO
  • TABLE 21 KEY PATENTS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, 2023-2025
  • TABLE 22 BEST PRACTICES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET
  • TABLE 23 CASE STUDIES RELATED TO AI IMPLEMENTATION IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET
  • TABLE 24 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET
  • TABLE 25 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 26 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 27 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 28 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 29 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 30 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES
  • TABLE 31 KEY BUYING CRITERIA FOR CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES
  • TABLE 32 RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 33 RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 34 RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 35 SINGLE-CHAMBER PACEMAKERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 36 DUAL-CHAMBER PACEMAKERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 37 LEADLESS CHAMBER PACEMAKERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 38 RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 39 RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY COUNTRY, 2024-2031(USD MILLION)
  • TABLE 40 KEY COMMERCIAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
  • TABLE 41 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 42 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 43 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICDS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 44 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICDS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 45 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICDS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 46 KEY COMMERCIAL EXTERNAL DEFIBRILLATORS
  • TABLE 47 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE , 2024-2031 (USD MILLION)
  • TABLE 48 EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 49 AUTOMATED EXTERNAL DEFIBRILLATORS (AEDS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 50 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 WEARABLE CARDIOVERTER DEFIBRILLATORS (WCDS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 52 CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS (CRT-P) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 53 CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS (CRT-P) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 54 CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATORS (CRT-D) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 55 RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 56 ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 57 ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 58 ELECTROCARDIOGRAM (ECG/EKG) MONITORS VOLUME, BY COUNTRY, 2024-2031 (THOUSAND UNITS)
  • TABLE 59 STANDARD 12-LEAD ECG MACHINES (RESTING ECG MONITORS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 STRESS ECG SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 61 STRESS ECG SYSTEMS VOLUME, BY COUNTRY, 2024-2031 (THOUSAND UNITS)
  • TABLE 62 HANDHELD/SMART ECG MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 63 AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 64 AMBULATORY CARDIAC MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 65 HOLTER MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 66 EVENT MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 67 MOBILE CARDIAC TELEMETRY (MCT) DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 68 LONG-TERM CONTINUOUS ECG MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 69 INVASIVE CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 70 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 71 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR ARRHYTHMIAS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 72 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR HEART FAILURE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 73 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR MYOCARDIAL INFARCTION (MI), 2024-2031 (USD MILLION)
  • TABLE 74 CARDIAC MONITORING AND RHYTHM MANAGEMENT MARKET DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 75 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 76 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 77 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR PRIMARY CARE CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 78 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC CENTERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 79 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 80 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 81 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 82 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 83 NORTH AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 84 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 85 NORTH AMERICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 86 NORTH AMERICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 87 NORTH AMERICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 88 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 89 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 90 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 91 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 92 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR EXTERNAL DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 93 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 94 NORTH AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 95 NORTH AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 96 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 97 US: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 98 US: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 99 US: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 100 US: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 101 US: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 102 US: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 103 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 104 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 105 US: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 106 US: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 107 US: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 108 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 109 CANADA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 110 CANADA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 111 CANADA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 112 CANADA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 113 CANADA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 114 CANADA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 115 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 116 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 117 CANADA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 118 CANADA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 119 CANADA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 120 EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 121 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 122 EUROPE: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 123 EUROPE: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 124 EUROPE: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 125 EUROPE: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 126 EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 127 EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 128 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 129 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 130 EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 131 EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 132 EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 133 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 134 GERMANY: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 135 GERMANY: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 136 GERMANY: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 137 GERMANY: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 138 GERMANY: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 139 GERMANY: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 140 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 141 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 142 GERMANY: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 143 GERMANY: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 144 GERMANY: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 145 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 146 FRANCE: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 147 FRANCE: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 148 FRANCE: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 149 FRANCE: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 150 FRANCE: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 151 FRANCE: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 152 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 153 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 154 FRANCE: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 155 FRANCE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 156 FRANCE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 157 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 158 UK: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 159 UK: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 160 UK: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 161 UK: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 162 UK: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 163 UK: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 164 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 165 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 166 UK: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 167 UK: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 168 UK: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 169 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 170 ITALY: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 171 ITALY: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 172 ITALY: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 173 ITALY: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 174 ITALY: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 175 ITALY: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 176 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 177 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 178 ITALY: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 179 ITALY: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 180 ITALY: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 181 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 182 SPAIN: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 183 SPAIN: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 184 SPAIN: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 185 SPAIN: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 186 SPAIN: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 187 SPAIN: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 188 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 189 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 190 SPAIN: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 191 SPAIN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 192 SPAIN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 193 AUSTRIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 194 AUSTRIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 195 AUSTRIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 196 AUSTRIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 197 AUSTRIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 198 AUSTRIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 199 AUSTRIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 200 AUSTRIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 201 AUSTRIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 202 AUSTRIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 203 AUSTRIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 204 AUSTRIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 205 NETHERLANDS: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 206 NETHERLANDS: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 207 NETHERLANDS: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 208 NETHERLANDS: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 209 NETHERLANDS: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 210 NETHERLANDS: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 211 NETHERLANDS: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 212 NETHERLANDS: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 213 NETHERLANDS: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 214 NETHERLANDS: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 215 NETHERLANDS: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 216 NETHERLANDS: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 217 SWEDEN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 218 SWEDEN: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 219 SWEDEN: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 220 SWEDEN: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 221 SWEDEN: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 222 SWEDEN: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 223 SWEDEN: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 224 SWEDEN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 225 SWEDEN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 226 SWEDEN: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 227 SWEDEN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 228 SWEDEN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 229 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 230 REST OF EUROPE: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 231 REST OF EUROPE: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 232 REST OF EUROPE: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 233 REST OF EUROPE: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 234 REST OF EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 235 REST OF EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 236 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 237 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 238 REST OF EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 239 REST OF EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 240 REST OF EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: CARDIAC MONITORING AND CARDIAC RHYTHM MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 244 ASIA PACIFIC: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION
  • TABLE 245 ASIA PACIFIC: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 246 ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 248 ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 249 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 251 ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 252 ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 253 ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 254 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 255 JAPAN: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 256 JAPAN: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 257 JAPAN: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 258 JAPAN: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 259 JAPAN: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 260 JAPAN: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 261 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 262 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 263 JAPAN: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 264 JAPAN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 265 JAPAN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 266 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 267 CHINA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 268 CHINA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 269 CHINA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 270 CHINA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 271 CHINA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 272 CHINA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 273 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 274 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 275 CHINA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 276 CHINA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 277 CHINA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 278 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 279 INDIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 280 INDIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 281 INDIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 282 INDIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 283 INDIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 284 INDIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 285 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 286 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 287 INDIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 288 INDIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 289 INDIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 290 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 291 AUSTRALIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 292 AUSTRALIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 293 AUSTRALIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 294 AUSTRALIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 295 AUSTRALIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 296 AUSTRALIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 297 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 298 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 299 AUSTRALIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 300 AUSTRALIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 301 AUSTRALIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 302 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 303 SOUTH KOREA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 304 SOUTH KOREA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 305 SOUTH KOREA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 306 SOUTH KOREA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 307 SOUTH KOREA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 308 SOUTH KOREA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 309 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 310 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 311 SOUTH KOREA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 312 SOUTH KOREA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 313 SOUTH KOREA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 314 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 315 REST OF ASIA PACIFIC: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 316 REST OF ASIA PACIFIC: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 317 REST OF ASIA PACIFIC: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 318 REST OF ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 319 REST OF ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 320 REST OF ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 321 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 322 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 323 REST OF ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 324 REST OF ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 325 REST OF ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 326 LATIN AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 327 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 328 LATIN AMERICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 329 LATIN AMERICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 330 LATIN AMERICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 331 LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 332 LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 333 LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 334 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 335 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 336 LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 337 LATIN AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 338 LATIN AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 339 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 340 BRAZIL: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 341 BRAZIL: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 342 BRAZIL: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 343 BRAZIL: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 344 BRAZIL: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 345 BRAZIL: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 346 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 347 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 348 BRAZIL: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 349 BRAZIL: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 350 BRAZIL: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 351 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 352 MEXICO: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 353 MEXICO: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 354 MEXICO: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 355 MEXICO: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 356 MEXICO: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 357 MEXICO: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 358 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 359 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 360 MEXICO: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 361 MEXICO: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 362 MEXICO: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 363 COLOMBIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 364 COLOMBIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 365 COLOMBIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 366 COLOMBIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 367 COLOMBIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 368 COLOMBIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 369 COLOMBIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 370 COLOMBIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 371 COLOMBIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 372 COLOMBIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 373 COLOMBIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 374 COLOMBIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 375 REST OF LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 376 REST OF LATIN AMERICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 377 REST OF LATIN AMERICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 378 REST OF LATIN AMERICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 379 REST OF LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 380 REST OF LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 381 REST OF LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 382 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 383 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 384 REST OF LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 385 REST OF LATIN AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 386 REST OF LATIN AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 387 MIDDLE EAST & AFRICA: CARDIAC MONITORING AND CARDIAC RHYTHM MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 388 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 389 MIDDLE EAST & AFRICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 390 MIDDLE EAST & AFRICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 391 MIDDLE EAST & AFRICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 392 MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 393 MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 394 MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 395 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 396 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 397 MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 398 MIDDLE EAST & AFRICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 399 MIDDLE EAST & AFRICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 400 GCC COUNTRIES: CARDIAC MONITORING AND CARDIAC RHYTHM MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 401 GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 402 GCC COUNTRIES: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 403 GCC COUNTRIES: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 404 GCC COUNTRIES: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 405 GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 406 GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 407 GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 408 GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 409 GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 410 GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 411 GCC COUNTRIES: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 412 GCC COUNTRIES: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 413 KINGDOM OF SAUDI ARABIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 414 KINGDOM OF SAUDI ARABIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 415 KINGDOM OF SAUDI ARABIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 416 KINGDOM OF SAUDI ARABIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 417 KINGDOM OF SAUDI ARABIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 418 KINGDOM OF SAUDI ARABIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 419 KINGDOM OF SAUDI ARABIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 420 KINGDOM OF SAUDI ARABIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 421 KINGDOM OF SAUDI ARABIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 422 KINGDOM OF SAUDI ARABIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 423 KINGDOM OF SAUDI ARABIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 424 KINGDOM OF SAUDI ARABIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 425 UAE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 426 UAE: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 427 UAE: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 428 UAE: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 429 UAE: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 430 UAE: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 431 UAE: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 432 UAE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 433 UAE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 434 UAE: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 435 UAE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 436 UAE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 437 REST OF GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 438 REST OF GCC COUNTRIES: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 439 REST OF GCC COUNTRIES: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 440 REST OF GCC COUNTRIES: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 441 REST OF GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 442 REST OF GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 443 REST OF GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 444 REST OF GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 445 REST OF GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 446 REST OF GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 447 REST OF GCC COUNTRIES: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 448 REST OF GCC COUNTRIES: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 449 REST OF MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 450 REST OF MIDDLE EAST & AFRICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 451 REST OF MIDDLE EAST & AFRICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 452 REST OF MIDDLE EAST & AFRICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024-2031 (USD MILLION)
  • TABLE 453 REST OF MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 454 REST OF MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 455 REST OF MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 456 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 457 REST OF MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 458 REST OF MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 459 REST OF MIDDLE EAST & AFRICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 460 REST OF MIDDLE EAST & AFRICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 461 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET
  • TABLE 462 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: DEGREE OF COMPETITION, 2025
  • TABLE 463 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: REGION FOOTPRINT
  • TABLE 464 CARDIAC MONITORING DEVICES MARKET: TYPE FOOTPRINT
  • TABLE 465 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: TYPE FOOTPRINT
  • TABLE 466 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: APPLICATION FOOTPRINT
  • TABLE 467 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 468 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY TYPE AND REGION
  • TABLE 469 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-NOVEMBER 2025
  • TABLE 470 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: DEALS, JANUARY 2023-NOVEMBER 2025
  • TABLE 471 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: EXPANSIONS, JANUARY 2023-NOVEMBER 2025
  • TABLE 472 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2023-NOVEMBER 2025
  • TABLE 473 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 474 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 475 GE HEALTHCARE: DEALS, JANUARY 2023-JANUARY 2026
  • TABLE 476 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2023-JANUARY 2026
  • TABLE 477 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 478 KONINKLIJKE PHILIPS N. V.: PRODUCTS OFFERED
  • TABLE 479 KONINKLIJKE PHILIPS N. V.: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
  • TABLE 480 KONINKLIJKE PHILIPS N. V.: DEALS, JANUARY 2023-JANUARY 2026
  • TABLE 481 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023-JANUARY 2026
  • TABLE 482 KONINKLIJKE PHILIPS N. V.: OTHER DEVELOPMENTS, JANUARY 2023-JANUARY 2026
  • TABLE 483 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 484 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 485 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2023-JANUARY 2026
  • TABLE 486 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2023-JANUARY 2026
  • TABLE 487 BAXTER (HILL-ROM HOLDINGS, INC.): COMPANY OVERVIEW
  • TABLE 488 BAXTER (HILL-ROM HOLDINGS, INC.): PRODUCTS OFFERED
  • TABLE 489 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 490 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 491 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2023-JANUARY 2026
  • TABLE 492 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 493 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
  • TABLE 494 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JANUARY 2026
  • TABLE 495 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2023-JANUARY 2026
  • TABLE 496 ABBOTT: COMPANY OVERVIEW
  • TABLE 497 ABBOTT: PRODUCTS OFFERED
  • TABLE 498 ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JANUARY 2026
  • TABLE 499 STRYKER: COMPANY OVERVIEW
  • TABLE 500 STRYKER: PRODUCTS OFFERED
  • TABLE 501 STRYKER: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
  • TABLE 502 STRYKER: DEALS, JANUARY 2023-JANUARY 2026
  • TABLE 503 STRYKER: OTHER DEVELOPMENTS, JANUARY 2023-JANUARY 2026
  • TABLE 504 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 505 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
  • TABLE 506 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 507 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 508 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023-JANUARY 2026
  • TABLE 509 FUKUDA DENSHI: COMPANY OVERVIEW
  • TABLE 510 FUKUDA DENSHI: PRODUCTS OFFERED
  • TABLE 511 OSI SYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 512 OSI SYSTEMS, INC.: PRODUCTS OFFERED
  • TABLE 513 OSI SYSTEMS, INC.: EXPANSIONS, JANUARY 2023-JANUARY 2026
  • TABLE 514 IRHYTHM INC.: COMPANY OVERVIEW
  • TABLE 515 IRHYTHM INC.: PRODUCTS OFFERED
  • TABLE 516 IRHYTHM INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023-JANUARY 2026
  • TABLE 517 IRHYTHM INC.: DEALS, JANUARY 2023-JANUARY 2026
  • TABLE 518 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW
  • TABLE 519 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED
  • TABLE 520 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
  • TABLE 521 ALIVECOR, INC.: COMPANY OVERVIEW
  • TABLE 522 ALIVECOR, INC.: PRODUCTS OFFERED
  • TABLE 523 ALIVECOR, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023-JANUARY 2026
  • TABLE 524 ALIVECOR, INC.: DEALS, JANUARY 2023-JANUARY 2026
  • TABLE 525 SCHILLER: COMPANY OVERVIEW
  • TABLE 526 CARDIAC INSIGHT, INC.: COMPANY OVERVIEW
  • TABLE 527 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 528 BITTIUM: COMPANY OVERVIEW
  • TABLE 529 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 530 LIFESIGNALS: COMPANY OVERVIEW
  • TABLE 531 CUMEDICAL: COMPANY OVERVIEW
  • TABLE 532 BIOTRICITY: COMPANY OVERVIEW
  • TABLE 533 EDAN INSTRUMENTS, INC.: COMPANY OVERVIEW
  • TABLE 534 VITALCONNECT: COMPANY OVERVIEW
  • TABLE 535 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: STUDY ASSUMPTIONS
  • TABLE 536 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: RISK ANALYSIS

List of Figures

  • FIGURE 1 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: YEARS CONSIDERED
  • FIGURE 3 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SCENARIO
  • FIGURE 4 GLOBAL CARDIAC MONITORING AND RHYTHM MANAGEMENT MARKET DEVICES MARKET SIZE, 2024-2031 (USD MILLION)
  • FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, 2022-2025
  • FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET
  • FIGURE 7 HIGH-GROWTH SEGMENTS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, 2026-2031
  • FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 9 HIGH CARDIOVASCULAR DISEASE INCIDENCE AND SHIFT TOWARD CONTINUOUS MONITORING TO ACCELERATE MARKET EXPANSION
  • FIGURE 10 CHINA AND ARRHYTHMIA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
  • FIGURE 11 INDIA TO WITNESS HIGHEST CAGR FROM 2026 TO 2031
  • FIGURE 12 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 13 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 14 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 15 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 16 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 17 AVERAGE SELLING PRICE OF HOLTER MONITORS, BY KEY PLAYER, 2025 (USD)
  • FIGURE 18 AVERAGE SELLING PRICE OF EXTERNAL DEFIBRILLATORS, BY KEY PLAYER, 2024 (USD)
  • FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET
  • FIGURE 20 INVESTMENT AND FUNDING SCENARIO FOR CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET PLAYERS
  • FIGURE 21 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: PATENT ANALYSIS, JANUARY 2014-NOVEMBER 2025
  • FIGURE 22 AI USE CASES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET
  • FIGURE 23 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES
  • FIGURE 24 KEY BUYING CRITERIA FOR CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICE PLAYERS
  • FIGURE 25 NORTH AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 26 ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, 2022-2024 (USD MILLION)
  • FIGURE 28 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SHARE ANALYSIS (2025)
  • FIGURE 29 US CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SHARE ANALYSIS (2025)
  • FIGURE 30 EUROPE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE ANALYSIS (2025)
  • FIGURE 31 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: BRAND COMPARATIVE ANALYSIS
  • FIGURE 32 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 33 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 34 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 35 EV/EBITDA OF KEY VENDORS
  • FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 38 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 39 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 40 BAXTER (HILL-ROM HOLDINGS, INC.): COMPANY SNAPSHOT
  • FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 42 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 43 ABBOTT: COMPANY SNAPSHOT
  • FIGURE 44 STRYKER: COMPANY SNAPSHOT
  • FIGURE 45 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
  • FIGURE 46 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 47 FUKUDA DENSHI: COMPANY SNAPSHOT
  • FIGURE 48 OSI SYSTEMS, INC.: COMPANY SNAPSHOT
  • FIGURE 49 IRHYTHM INC.: COMPANY SNAPSHOT
  • FIGURE 50 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 51 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: RESEARCH DESIGN
  • FIGURE 52 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 53 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: KEY PRIMARY SOURCES
  • FIGURE 54 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: INSIGHTS FROM KEY PRIMARIES
  • FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 56 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 57 CARDIAC MONITORING DEVICES MARKET (INVASIVE AND NON-INVASIVE DEVICE TYPE) SIZE ESTIMATION: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)
  • FIGURE 58 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: TOP-DOWN APPROACH
  • FIGURE 59 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: BOTTOM-UP APPROACH
  • FIGURE 60 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: CAGR PROJECTIONS (SUPPLY SIDE)
  • FIGURE 61 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: DATA TRIANGULATION METHODOLOGY
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!